The expression levels of CCT2, CCT3, CCT4, CCT5, CCT6A, CCT7, and CCT8 were compared between patients with low and high stage HCC in the TCGA cohort (Figure 1C). The gene discussed is CCT6A; the disease is hepatocellular carcinoma.